Legal Representation
Attorney
Michael J. Striker
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 26, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 26, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 5, 2009 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 5, 2009 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 5, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 3, 2008 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 3, 2008 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 3, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 25, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 1, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 12, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 27, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 26, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 20, 2007 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Nov 20, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 20, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 17, 2007 | FAXX | I | FAX RECEIVED | Loading... |
| Oct 11, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 24, 2007 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 24, 2007 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 24, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 23, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 25, 2007 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of varicose veins and hemorrhoids; pharmaceutical preparations, namely, agents for use in the treatment of scierose and vascular disease, medicaments for use in the treatment of vascular disease
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005